Skip to main content

Table 3 Associations of OST with patient- and disease-associated characteristics

From: Optical spectral transmission to assess glucocorticoid therapy response in patients with arthritis: a longitudinal follow-up comparison with joint ultrasound

 

Time-point (a)

Time-point (b)

Rho

Significance p

Rho

Significance p

Age (years)b

0.043

0.760

-

-

BMIb

0.315

0.021*

-

-

Handsize, %b

0.136

0.331

0.201

0.150

ESR, mm/ha

0.041

0.768

0.057

0.683

DAS28a

0.239

0.081

0.160

0.248

PDUSa

0.449

0.001**

0.414

0.002**

GSUSa

0.494

0.0002***

0.56

<0.0001***

Tenosynovitisa

−0.059

0.688

−0.025

0.857

TJCa

−0.064

0.645

−0.077

0.581

SJCa

0.379

0.005**

0.382

0.004**

VASa

0.135

0.330

-0.016

0.910

 

Tme-point (a)

Time-point (b)

Median ± SD

Significance p

Median ± SD

Significance p

Genderb

0.320

 Female

18.15 ± 4.80

0.687

15.96 ± 4.86

 Male

18.69 ± 4.57

17.38 ± 4.85

Arterial hypertensionb

0.849

 No

18.91 ± 4.23

0.359

16.56 ± 4.66

 Yes

17.72 ± 5.15

16.30 ± 5.15

Diabetes mellitus IIb

0.844

 No

18.46 ± 4.82

0.369

16.41 ± 5.07

 Yes

16.98 ± 3.06

16.63 ± 1.80

Nicotineb

0.412

 No

17.81 ± 4.24

0.230

16.10 ± 4.68

 Yes

16.09 ± 17.50

17.50 ± 5.43

  1. Spearman’s (anot normal distribution) and Pearson’s (bnormal distribution) tests were performed to investigate the relationships between OST and quantitative patient characteristics. t-test was used to investigate the relationships between OST and qualitative patient characteristics. bData are presented as mean (± SD), as normally distributed
  2. BMI Body mass index, ESR Erythrocyte sedimentation rate, DAS28 Disease activity score 28, PDUS Power Doppler ultrasound score, GSUS Grayscale ultrasound score, TJC Tender joint count, SJC Swollen joint count, VAS Visual analogue scale
  3. *p < 0.05, **p < 0.01, ***p < 0.001